Skip to main content
OpenTrials

Clinical trial condition

Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia

Explore clinical trials studying Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Minimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia trial results

Active, Not Recruiting

A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia

NCT07134088

Conditions
Burkitt Lymphoma, DNA Virus Infections, Disease Attributes, +22 more
Locations
  • Lucile Packard Childrens Hospital Stanford Palo Alto, California, United States
  • Childrens Hospital of Philadelphia Philadelphia, Pennsylvania, United States
  • St Jude Childrens Research Hospital Memphis, Tennessee, United States
  • Seattle Childrens Hospital Seattle, Washington, United States
View Trial Details

Related conditions